You are here
Oral oestrogen therapy
Porphyria cutanea tarda - Oral oestrogen therapy Factor
Last reviewed for CCPS 18 May 2001.
Preliminary questions [30484]
30509 there is some evidence that oral oestrogen therapy may be a factor in the development or worsening of the condition under consideration.
30510 the veteran has undergone a course of oral oestrogen therapy at some time.
30513 — the veteran has established the causal connection between the oral oestrogen therapy and VEA service for porphyria cutanea tarda.
35807 the veteran has undergone a course of oral oestrogen therapy for the 30 days immediately before the clinical onset of the condition under consideration. 30515 — the veteran has established the causal connection between the oral oestrogen therapy and VEA service for the clinical onset of porphyria cutanea tarda. 30518 — the veteran has established the causal connection between the oral oestrogen therapy and operational service for the clinical onset of porphyria cutanea tarda. or 30519 — the veteran has established the causal connection between the oral oestrogen therapy and eligible service for the clinical onset of porphyria cutanea tarda. or 30517 — the veteran has established the causal connection between the oral oestrogen therapy and VEA service for the clinical worsening of porphyria cutanea tarda. 30520 — the veteran has established the causal connection between the oral oestrogen therapy and operational service for the clinical worsening of porphyria cutanea tarda. or 30521 — the veteran has established the causal connection between the oral oestrogen therapy and eligible service for the clinical worsening of porphyria cutanea tarda. Clinical onset and operational service [30518] or 30522 — the identified illness or injury for which the course of oral oestrogen therapy was undergone is causally related to operational service. Clinical onset and eligible service [30519] or 30523 — the identified illness or injury for which the course of oral oestrogen therapy was undergone is causally related to eligible service. Clinical worsening and operational service [30520] or 30522 — the identified illness or injury for which the course of oral oestrogen therapy was undergone is causally related to operational service. Clinical worsening and eligible service [30521] or 30523 — the identified illness or injury for which the course of oral oestrogen therapy was undergone is causally related to eligible service.